Ardagh Group S.A. provides an update on discussions with noteholders
LUXEMBOURG, April 7, 2025 /PRNewswire/ -- On 11 March 2025, Ardagh Group S.A. ('AGSA' or the 'Company') announced that it is engaging in negotiations with certain holders of its Senior Secured Notes ('SSNs') and Senior Unsecured Notes ('SUNs') who comprise two separate ad hoc groups of AGSA's debt. A group owning a majority of the SUNs are represented by Akin Gump Strauss Hauer & Feld LLP and PJT Partners ('SUN Group'). Another group owning a majority of the SSNs are represented by Gibson, Dunn & Crutcher LLP and Perella Weinberg Partners ('SSN Group').
The Company continues to engage in constructive discussions with the SUN Group and the SSN Group regarding the terms of a potential restructuring transaction.
As an update to the announcement on 11 March 2025, the latest proposal received from the SSN Group (the 'SSN Proposal') includes the following key terms for a transaction:
a potential divestment (subject to AGSA board approval) of the ordinary shares in Ardagh Metal Packaging S.A. ('AMP Shares') to a new special purpose vehicle holding structure ('New BidCo') owned by existing indirect shareholders of AGSA (the 'Existing Shareholders') and by participating holders of the SUNs. The existing preferred equity issued by Ardagh Metal Packaging S.A. to AGSA's subsidiary, Ardagh Investments Holdings Sarl's ('AIHS') would remain at AIHS;
at completion, the pro forma equity in New Bidco would be held 80% by the Existing Shareholders and 20% by holders of the SUNs (subject to an allocation to participating holders of the senior secured toggle notes due 2027 issued by ARD Finance S.A. (the 'PIK Notes')), with pro-rata allocation based on participation rate;
the exchange of the SSNs into (i) up to $1,892 million of new senior secured debt at AGSA, which would have second-out priority in respect of proceeds from security enforcement, would mature in June 2030, bear interest at 6.0% cash and 6.0% PIK interest, and have call protection of NC2, 50%, 25%, Par (the 'AGSA Exchange SSNs'); and (ii) $600 million of new first lien senior secured debt at New BidCo, which would be backstopped by the Steering Committee of the SSN Group with a 5.0% backstop fee payable in kind, have security granted over substantially all the assets of New Bidco, would mature in June 2030, bear 12.0% cash interest, and have call protection of NC2, 50%, 25%, Par (the 'New Bidco Debt');
participating SSN holders would agree to provide the Company with basket capacity available through August 2026 maturity for the incurrence of new debt that would rank the same as the AGSA Exchange SSNs to facilitate a refinancing of non-participating SSNs with the AGSA Exchange SSNs benefitting from a 'most favoured nations' clause in relation to the terms of the new debt issued or exchanged via this basket;
existing holders of SSNs would be entitled to participate in a $1,200 million super senior new money facility at AGSA (the 'AGSA New Money'), which would have first-out priority in respect of proceeds from security enforcement. $400 million would be applied towards general corporate purposes and $800 million would be applied towards the refinancing of AIHS's existing term loan facility (the 'AIHS Facility'). The facility would mature in January 2030 (with a springing maturity), have call protection of NC2, 50%, Par, bear 9.0% cash interest, and would be backstopped by the Steering Committee of the SSN Group;
participating SUNs would exchange pro rata into (i) new debt at AGSA, which would have third-out priority in respect of proceeds from security enforcement, mature in June 2030 with a springing maturity, bear 12.0% PIK interest, and have call protection of NC2, 50%, 25%, Par (except on conversion) (the 'AGSA Exchange SUNs'); and (ii) $511 million of a new preferred equity instrument issued by New BidCo which would be subject to a mandatory redemption offer obligation in June 2030 (the 'New Bidco Pref B'). Participating SUN holders would also receive a 7.5% upfront fee paid in the form of additional AGSA Exchange SUNs;
participating holders of PIK Notes would exchange into new debt at AGSA which would have fourth-out priority in respect of proceeds from security enforcement, mature in June 2030 with a springing maturity, bear 12.0% PIK interest, and have call protection of NC2, 50%, 25%, Par (except on conversion) (the 'AGSA Exchange PIKs');
the AGSA Exchange SUNs and AGSA Exchange PIKs would be convertible into AGSA equity subject to an agreed participation threshold by participating SUN and PIK Notes;
the consideration for the sale of the AMP Shares to New Bidco would comprise: (i) $600 million of SSNs being exchanged into the New Bidco Debt, (ii) a $763 million new preferred equity instrument issued by New BidCo to AGSA's subsidiary, AIHS, which would be subject to a mandatory redemption offer obligation in June 2030 and pay a dividend at an annual rate of 14.15% in cash or, on up to three dividend payment dates on which available cashflow is insufficient to pay such dividend in cash, in kind (the 'New Bidco Pref A'), (iii) the partial exchange of SUNs into $511 million of the New Bidco Pref B. Existing Shareholders would also receive $57 million of New BidCo Pref B; and
the collateral for the AGSA Exchange SSNs, the AGSA Exchange SUNs, the AGSA Exchange PIKs and the AGSA New Money would be the same collateral as per the existing SSNs plus security over certain currently unpledged assets including over the Ardagh Glass Packaging Africa group (directly or indirectly), AGSA's equity interests in the Trivium group, the New Bidco Pref A, and other assets where practicable.
After receiving the SSN Proposal, the Company shared a proposal with the SSN Group including the following key terms for a transaction:
a potential divestment (subject to AGSA board approval) of the AMP Shares and the preferred equity in AMP currently held indirectly by AGSA to New BidCo (together with the AMP Shares, the 'AMP Interests');
at completion, the pro forma equity in New Bidco would be held 80% by the Existing Shareholders and 20% by holders of the SUNs, with pro-rata allocation based on participation rate;
the exchange of the SSNs into (i) $1,892 million of new senior secured debt at AGSA, which would have second-out priority in respect of proceeds from security enforcement, would mature in June 2030 (with a springing maturity), would bear interest at an annual rate of 9.0% (4.0% cash; 5.0% PIK), and would have no call protection (the 'Company AGSA Exchange SSNs'); and (ii) $600 million of new first lien senior secured debt at New BidCo, which would have security granted over substantially all the assets of New Bidco, would mature in June 2030, and would bear 6.25% cash interest, subject to the ability to pay in kind to the extent New BidCo were to have insufficient cash flow and would have no call protection (the 'Company New Bidco Debt'). The exchange of SSNs into the Company New Bidco Debt would be backstopped by the Steering Committee of the SSN Group and (only in the case of a transaction with the consent of the SUN Group) the SUN Group with a 5.0% backstop fee payable kind. Non-participating SSNs would be left outstanding on their current terms;
participating SSN holders would agree to provide the Company with basket capacity for the incurrence of new debt that would rank the same as the AGSA Exchange SSNs to facilitate a refinancing of non-participating SSNs, with the Steering Committee of the SSN Group benefitting from a right of first refusal in relation to the new debt issued or exchanged via this basket;
existing holders of SSNs would be entitled to participate in a $1,210 million super senior new money facility at AGSA (the 'Company AGSA New Money'), which would have first-out priority in respect of proceeds from security enforcement. $400 million would be applied towards general corporate purposes, $800 million would be applied towards the refinancing of the AIHS Facility, and $10 million would be applied towards funding New BidCo's balance sheet. The facility would mature in January 2030 (with a springing maturity), have call protection of NC2, 50%, Par, (only in the case of a transaction with the consent of the SUN Group), bear 8.5% cash interest, and would be backstopped by the Steering Committee of the SSN Group and (only in the case of a transaction with the consent of the SUN Group) the SUN Group in case of their later participation in the transaction;
participating SUNs would exchange pro rata into (i) new debt at AGSA, which would be pari passu to existing SUNs, would mature in June 2030 (with a springing maturity), and bear 12.0% PIK interest (the 'Company AGSA Exchange SUNs'); and (ii) $511 million of a new preferred equity instrument issued by New BidCo which would be subject to a mandatory redemption offer obligation in June 2030 and pay a cash dividend of 12.5%, subject to the ability to pay in kind to the extent New BidCo were to have insufficient cash flow (the 'Company New Bidco Pref B'). Participating SUN holders would also receive a 20.0% fee paid in the form of additional Company AGSA Exchange SUNs;
the Company AGSA Exchange SUNs would be convertible into AGSA equity on terms to be agreed;
consideration to be provided to holders of PIK Notes to be agreed;
the consideration for the sale of the AMP Interests to New Bidco would comprise: (i) $600 million of SSNs being exchanged into the Company New Bidco Debt, (ii) $1,023 million of a new preferred equity instrument being issued by New BidCo to AIHS, which would be subject to a mandatory redemption offer obligation in June in 2030 and pay a cash dividend of 9.4% (subject to the ability to pay in kind to the extent New BidCo were to have insufficient cash flow) (the 'Company New Bidco Pref A'), and (iii) the partial exchange of SUNs into $511 million of the Company New Bidco Pref B. Existing Shareholders would also receive $57 million of Company New BidCo Pref B; and
the collateral for the Company AGSA Exchange SSNs and the Company AGSA New Money would be the same collateral as per the existing SSNs plus security over certain currently unpledged assets including over the Ardagh Glass Packaging Africa group (directly or indirectly), the Company New Bidco Pref A, AGSA's equity interests in the Trivium group and other assets where practicable.
The Company will provide further updates in due course.
Disclaimer
This release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities referred to in this announcement, in any jurisdiction, including the United States, in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, or an exemption from registration.
This release contains 'forward-looking' information. The forward-looking information is based upon certain assumptions about future events or conditions and is intended to illustrate hypothetical results under those conditions. Actual events or conditions are unlikely to be consistent with, and may materially differ from, those assumed. Any views or opinions expressed in this release (including statements or forecasts) constitute the judgement of the Company as of the date of this material and are subject to change without notice. You are cautioned not to place undue reliance on any forward-looking information.
Any projections or forecasts in this release are illustrative only and have been based on the estimates and assumptions when the Company's business plan was prepared. Such estimates and assumptions may or may not prove to be correct. These projections do not constitute a forecast or prediction of actual results and there can be no assurance that the projected results will actually be realized or achieved. Actual results may depend on future events which are not in the Company's control and may be materially affected by unforeseen economic or other circumstances.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)-- Cyanotech Corporation (OTCQB Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2025, ended March 31, 2025. Commenting on the fiscal year results (changes shown vs. fiscal 2024), Cyanotech's President and Chief Executive Officer, Matthew K. Custer, said: 'Fiscal 2025 was a year of meaningful progress for Cyanotech. Revenue grew 5%, gross margin improved by nearly 3 points and we reduced our operating loss by almost 45%.' 'Looking ahead, we remain cautious. Economic uncertainty, shifting demand and potential new tariffs could impact costs and global markets. We are focused on staying flexible, managing expenses and strengthening our customer relationships to navigate these challenges.' 'While I am proud of this year's progress, we know there is more to do. Our priority continues to be driving awareness of our naturally farmed microalgae from our farm in Kona, Hawaii.' Fiscal Year 2025 Cyanotech reported net sales of $24,215,000 for fiscal 2025 compared to $23,071,000 in fiscal 2024, an increase of 5.0%. Gross profit was $6,876,000, with a gross profit margin of 28.4%, compared to gross profit of $5,945,000 and gross profit margin of 25.8%. The operating loss was $2,508,000 compared to an operating loss of $4,592,000. Net loss was $3,203,000 or $0.45 loss per share, compared to net loss of $5,267,000 or $0.81 earnings per share. Fourth Quarter Fiscal 2025 Cyanotech reported net sales of $6,300,000 for the fourth quarter of fiscal year 2025 compared to $5,970,000 in the fourth quarter of fiscal 2024, an increase of 5.5%. Gross profit was $1,742,000 with a gross profit margin of 27.7%, compared to gross profit of $675,000 and gross profit margin of 11.3% in the fourth quarter of fiscal 2024. Operating loss was $442,000 compared to operating loss of $1,903,000 in the fourth quarter of fiscal 2024. Net loss was $627,000, or $0.09 loss per share, compared to net loss of $2,081,000, or $0.30 loss per share in the fourth quarter of fiscal 2024. Please review the Company's Form 10-K for the period ended March 31, 2025 for more detailed information. — Cyanotech will host a broadcast at 8:00 PM ET on Monday, June 23, 2025, to respond to questions about its operating results and other topics of interest. Interested parties are asked to submit questions to questions@ before 12 p.m. ET on Monday, June 23, 2025. The Company will respond only to relevant questions relating to the Company's fourth quarter and fiscal 2025 financial performance and will not be accepting any questions or comments during the broadcast. To join the broadcast, please browse approximately five minutes prior to the start time. About Cyanotech — Cyanotech Corporation, a world leader in microalgae technology for more than 40 years, produces BioAstin ® Hawaiian Astaxanthin ® and Hawaiian Spirulina Pacifica ®. These all-natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. The Company's mission is to fulfill the promise of whole health through Hawaiian microalgae. Cyanotech's BioAstin ® offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise †. Cyanotech's Spirulina products offer nutrition that supports cardiovascular health and immunity †. All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, Hawaii using patented and proprietary technology and are Generally Recognized as Safe ('GRAS') for use in food products. Cyanotech sells its products direct to consumers at retail locations in the United States and online at and also distributes to dietary supplement, nutraceutical and cosmeceutical manufacturers and marketers. The Company is regulated by the Food and Drug Administration. Visit for more information. † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Expand 'Safe Harbor ' Statement under the U.S. Private Securities Litigation Reform Act of 1995 Besides statements of present fact and historical fact, this press release may contain forward-looking statements. Forward-looking statements relate to the future and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by forward-looking statements. We caution against relying on forward-looking statements. Important factors that could change actual, future results include: changes in sales levels to our largest customers, weather patterns in Hawaii, production problems, risks associated with new products, foreign exchange fluctuations, availability of financing, and our ability to continue as a going concern, as well as national and global political, economic, business, competitive, market and regulatory conditions. Other factors are more fully detailed in the Company's annual Form 10-K filings with the Securities and Exchange Commission. Financial Tables Follow: The following tables do not contain footnotes or other information contained in the Company's Form 10-K for the fiscal year ended March 31, 2025, which can be found on the Cyanotech website ( under Investors>Investor Filings upon filing. As such the following Financial Tables are provided only as a guide and other factors are more fully detailed in the Company's annual Form 10-K filings with the Securities and Exchange Commission. March 31, 2025 2024 (in thousands, except share data) ASSETS Current assets: Cash $ 257 $ 707 Accounts receivable, net of allowance for credit losses of $16 in 2025 and $11 in 2024 1,953 2,102 Inventories 7,788 7,313 Prepaid expenses and other current assets 547 469 Total current assets 10,545 10,591 Equipment and leasehold improvements, net 8,927 10,109 Operating lease right-of-use assets, net 3,902 4,284 Other assets 116 128 Total assets $ 23,490 $ 25,112 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 2,217 $ 1,439 Accrued expenses 715 757 Customer deposits 110 198 Operating lease obligations, current portion 555 530 Short term debt – bank 760 1,240 Line of credit – related party 3,000 1,250 Current maturities of long-term debt 2,886 3,140 Total current liabilities 10,243 8,554 Long-term debt – related party 1,000 1,000 Long-term operating lease obligations 3,363 3,744 Total liabilities 14,606 13,298 Commitments and contingencies Stockholders' equity: Preferred stock of $0.01 par value, 10,000,000 shares authorized; no shares issued and outstanding — — Common stock of $0.02 par value, 50,000,000 shares authorized; 7,199,908 shares at March 31, 2025 and 6,947,246 shares at March 31, 2024 issued and outstanding 144 139 Additional paid-in capital 34,844 34,576 Accumulated deficit (26,104 ) (22,901 ) Total stockholders' equity 8,884 11,814 Total liabilities and stockholders' equity $ 23,490 $ 25,112 Expand CYANOTECH CORPORATION Fiscal years ended March 31, 2025 2024 (in thousands) Net sales $ 24,215 $ 23,071 Cost of sales 17,339 17,126 Gross profit 6,876 5,945 Operating expenses: General and administrative 4,397 4,464 Sales and marketing 4,538 5,384 Research and development 449 689 Total operating expense 9,384 10,537 Loss from operations (2,508 ) (4,592 ) Other income (expense): Interest expense, net (687 ) (668 ) Loss before income tax expense (3,195 ) (5,260 ) Income tax expense (8 ) (7 ) Net loss $ (3,203 ) $ (5,267 ) Net loss per share: Basic and diluted $ (0.45 ) $ (0.81 ) Shares used in calculation of net loss per share: Basic and diluted 7,071 6,531 Expand
Yahoo
3 hours ago
- Yahoo
Northpointe Bancshares, Inc. Announces Date of Second Quarter 2025 Earnings Release and Conference Call
GRAND RAPIDS, Mich., June 20, 2025--(BUSINESS WIRE)--Northpointe Bancshares, Inc. (NYSE: NPB), the holding company of Northpointe Bank, announced today that it will release its second quarter 2025 financial results on Tuesday, July 22, 2025, after market close. The earnings release will be available in the "Investor Relations" section of the Company's website, The Company will host a conference call for investors and analysts at 10:00 a.m. E.T. on July 23, 2025. During the call, management will discuss the second quarter 2025 financial results and provide an update on recent activities. There will be a live question-and-answer session following the presentation. It is recommended you join 10 minutes prior to the start time. Participants may access the live conference call by dialing 1-877-413-2414 and requesting "Northpointe Bancshares Inc. Conference Call". The conference call will also be webcast live at An audio archive will be available on the website following the call. About Northpointe Bancshares, Inc.: Headquartered in Grand Rapids, Michigan, Northpointe Bancshares, Inc. is the holding company of Northpointe Bank, a client-focused company that provides home loans and retail banking products to communities across the nation. Our mission is to be the best bank in America by bringing value and innovation to the people we serve. To learn more visit View source version on Contacts Kevin Comps, President616-974-8491 | Brad Howes, CFO616-726-2585 | Sign in to access your portfolio
Business Wire
3 hours ago
- Business Wire
Northpointe Bancshares, Inc. Announces Date of Second Quarter 2025 Earnings Release and Conference Call
GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Northpointe Bancshares, Inc. (NYSE: NPB), the holding company of Northpointe Bank, announced today that it will release its second quarter 2025 financial results on Tuesday, July 22, 2025, after market close. The earnings release will be available in the "Investor Relations" section of the Company's website, The Company will host a conference call for investors and analysts at 10:00 a.m. E.T. on July 23, 2025. Management will discuss the second quarter 2025 financial results and provide an update on recent activities. Share The Company will host a conference call for investors and analysts at 10:00 a.m. E.T. on July 23, 2025. During the call, management will discuss the second quarter 2025 financial results and provide an update on recent activities. There will be a live question-and-answer session following the presentation. It is recommended you join 10 minutes prior to the start time. Participants may access the live conference call by dialing 1-877-413-2414 and requesting 'Northpointe Bancshares Inc. Conference Call'. The conference call will also be webcast live at An audio archive will be available on the website following the call. About Northpointe Bancshares, Inc.: Headquartered in Grand Rapids, Michigan, Northpointe Bancshares, Inc. is the holding company of Northpointe Bank, a client-focused company that provides home loans and retail banking products to communities across the nation. Our mission is to be the best bank in America by bringing value and innovation to the people we serve. To learn more visit
